Electroacupuncture plus moxibustion therapy for patients with major depressive disorder: study protocol for a randomized controlled trial

Abstract

BackgroundMajor depressive disorder (MDD) is one of the most prevalent mental health disorders and has a significant societal economic burden. Antidepressants and cognitive behavioral therapy are two primary interventions for the standardized treatment of MDD. However, their weaknesses, such as a low response rate, a high risk of adverse events from medication, and the high cost of cognitive behavioral therapy, have resulted in a need for complementary and alternative medicine (CAM). Among the various therapeutic interventions in CAM, electroacupuncture and moxibustion have been widely used to treat various mental illnesses, including MDD. The aim of this study is to evaluate the feasibility of conducting a full-scale randomized controlled trial to investigate the efficacy and safety of electroacupuncture plus moxibustion therapy for MDD.Methods/designWe will include patients between the ages of 19 to 65 years with MDD. A total of 30 participants will be recruited, and they will be randomly allocated into two groups at a 1:1 ratio. Patients in the treatment and control groups will, respectively, receive real and sham electroacupuncture/moxibustion treatments, for a total of 20 sessions over 8 weeks. The primary outcome will be the Hamilton Rating Scale for Depression, and the secondary outcomes will be Beck’s Depression Inventory, the Insomnia Severity Index, the State-Trait Anxiety Inventory, the EuroQol 5-Dimension Index, the Measure Yourself Medical Outcome Profile version 2, and electroencephalography. Adverse events will be monitored at each visit to assess safety. All outcomes will be assessed and analyzed by researchers blinded to the treatment allocation.DiscussionThis is a two-armed, parallel-design, patient-assessor blinded, multicenter, randomized, sham-controlled pilot clinical trial. Data will be analyzed before and after treatment and during a 4-week follow-up. The results of the trial will provide a basis for further studies assessing the efficacy and safety of electroacupuncture plus moxibustion treatment for MDD.Trial registrationKorean Clinical Trial Registry, CRIS-KCT0001810. Registered on 5 February 2016 (retrospectively registered; date of enrollment of the first participant to the trial: 2 December 2015).Electronic supplementary materialThe online version of this article (doi:10.1186/s13063-016-1741-2) contains supplementary material, which is available to authorized users.

Acupuncture modulates stress response by the mTOR signaling pathway in a rat post-traumatic stress disorder model

“…Acupuncture is known to stabilize the central nervous system (CNS) and control the HPA axis to treat stress-induced diseases. In addition, acupuncture is used for depression and anxiety, which are the most frequent complaints of psychiatric complaints in Complementary Alternative Medicine (CAM) clinic 16 – 21 . Acupoint HT8 has been used to sedate “ Fire qi ” according to Sa-Am acupuncture theory of Korean Medicine, with our interpretation of reducing depression or anxiety.…”

Mechanisms Underlying the Antidepressant Effect of Acupuncture via the CaMK Signaling Pathway

“…Electroacupuncture has been broadly used to treat various mood disorders for decades Kim et al, 2017;Zeng et al, 2018). In this study, we stimulated the Baihui (GV20) and Shenting (GV24) acupoints with electroacupuncture instruments.…”

The efficacy of Tuina with herbal ointment for patients with post-stroke depression: study protocol for a randomized controlled trial

“…First, participants lie on the massage bed in a prone or side position. The acupoints of Du meridian which can improve depression on the back will be located and marked as Baihui (GV20), Dazhui (GV14), Zhiyang (GV9), Mingmen (GV4), and Changqiang (GV1) [34][35][36][37][38]. Apply 1 to 3 g of herbal ointment evenly to each acupoints.…”